Expand CAI Menu
CAI MENU

Caris Life Sciences (CAI) closed at $17.58 on November 20, 2026, down 5.2% from the previous close, on volume of 4,123,892 shares (30-day average 3,769,967).

Key numbers
  • Last close: $17.58 (November 20, 2026)
  • 52-week range: $14.19 to $36.50
  • Market value: $5.0 billion
  • 30-day implied volatility (IV30): 44.7%
  • Option volume: 720 contracts (684 calls, 36 puts); 30-day average 533

Data as of November 20, 2026.

CAI Stock Summary and Trading Ideas (Caris Life Sciences | NASDAQ:CAI)

Charts for Today's Stock Price and Implied Volatility in Caris Life Sciences

20-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for CAI by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 2, 2026 Call Spread 15-Jan-2730 : 35 C 2,800
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days

News

Diagnostic stocks safe from proposed crackdown on Medicare fraud

Seeking Alpha News (Tue, 17-Nov 10:41 AM ET)

Trading Statistics

Key Ratios

Caris Life Sciences (CAI) Frequently Asked Questions

What does Caris Life Sciences do?

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

What symbol and exchange does Caris Life Sciences shares trade?

Caris Life Sciences trades on the NASDAQ stock market under the symbol CAI.

What is Caris Life Sciences stock price doing today?

As of November 20, 2026, CAI stock price declined to $17.58 with 4,123,892 million shares trading.

What is Caris Life Sciences's Beta?

CAI has a beta of 2.46, meaning it tends to be more sensitive to market movements. CAI has a correlation of 0.23 to the broad based SPY ETF.

How much is Caris Life Sciences worth?

CAI has a market cap of $5.04 billion. This is considered a Mid Cap stock.

How much money does Caris Life Sciences make?

Last quarter Caris Life Sciences reported $275 million in Revenue and $.05 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.03.

What are the top ETFs holding Caris Life Sciences?

The top ETF exchange traded funds that CAI belongs to (by Net Assets): VTI, VB, VBK, VXF, IBB.

Is Caris Life Sciences (CAI) a good investment?

CAI has underperformed the market in the last year with a price return of -26.8% while the SPY ETF gained +6.9%. CAI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.5% and -30.3%, respectively, while the SPY returned -9.3% and -6.2%, respectively.

What are the support and resistance levels for Caris Life Sciences (CAI)?

CAI support price is $17.59 and resistance is $19.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAI shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes